These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31428323)

  • 1. A gastrointestinal simulation system for dissolution of oral solid dosage forms before and after Roux-en-Y gastric bypass.
    Yska JP; Punter RJ; Woerdenbag HJ; Emous M; Frijlink HW; Wilffert B; van Roon EN
    Eur J Hosp Pharm; 2019 May; 26(3):152-156. PubMed ID: 31428323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Roux-en-Y gastric bypass on the bioavailability of metoprolol from immediate and controlled release tablets: a single oral dose study before and after surgery.
    Yska JP; Wanders JTM; Odigie B; Apers JA; Emous M; Totté ERE; Boerma EC; Ubels FL; Woerdenbag HJ; Frijlink HW; Wilffert B; van Roon EN
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e19-e24. PubMed ID: 32296500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations.
    Gesquiere I; Darwich AS; Van der Schueren B; de Hoon J; Lannoo M; Matthys C; Rostami A; Foulon V; Augustijns P
    Br J Clin Pharmacol; 2015 Nov; 80(5):1021-30. PubMed ID: 25917170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution of common psychiatric medications in a Roux-en-Y gastric bypass model.
    Seaman JS; Bowers SP; Dixon P; Schindler L
    Psychosomatics; 2005; 46(3):250-3. PubMed ID: 15883146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting iron absorption from an effervescent iron supplement in obese patients before and after Roux-en-Y gastric bypass: a preliminary study.
    Gesquiere I; Steenackers N; Lannoo M; Foulon V; Mertens A; Gils A; de Hoon J; Augustijns P; Matthys C; Van der Schueren B
    J Trace Elem Med Biol; 2019 Mar; 52():68-73. PubMed ID: 30732902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of USP apparatus 3 for dissolution testing of immediate-release products.
    Yu LX; Wang JT; Hussain AS
    AAPS PharmSci; 2002; 4(1):E1. PubMed ID: 12049485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a three compartment in vitro gastrointestinal simulator dissolution apparatus to predict in vivo dissolution.
    Takeuchi S; Tsume Y; Amidon GE; Amidon GL
    J Pharm Sci; 2014 Nov; 103(11):3416-3422. PubMed ID: 25251982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-nanoemulsifying drug delivery systems ameliorate the oral delivery of silymarin in rats with Roux-en-Y gastric bypass surgery.
    Chen CH; Chang CC; Shih TH; Aljuffali IA; Yeh TS; Fang JY
    Int J Nanomedicine; 2015; 10():2403-16. PubMed ID: 25848259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug disposition before and after gastric bypass: fenofibrate and posaconazole.
    Gesquiere I; Hens B; Van der Schueren B; Mols R; de Hoon J; Lannoo M; Matthys C; Foulon V; Augustijns P
    Br J Clin Pharmacol; 2016 Nov; 82(5):1325-1332. PubMed ID: 27367040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate.
    Ijaz H; Qureshi J; Danish Z; Zaman M; Abdel-Daim M; Hanif M; Waheed I; Mohammad IS
    Pak J Pharm Sci; 2015 Nov; 28(6):2019-25. PubMed ID: 26639495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations.
    Rekhi GS; Eddington ND; Fossler MJ; Schwartz P; Lesko LJ; Augsburger LL
    Pharm Dev Technol; 1997 Feb; 2(1):11-24. PubMed ID: 9552427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Roux-en-Y gastric bypass on the pharmacokinetic-pharmacodynamic relationships of liquid and controlled-release formulations of oxycodone.
    Ladebo L; Abuhelwa AY; Foster DJR; Kroustrup JP; Pacyk GJ; Kongstad KT; Drewes AM; Christrup LL; Olesen AE
    Basic Clin Pharmacol Toxicol; 2021 Sep; 129(3):232-245. PubMed ID: 34228875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.
    Krishnaiah YS; Karthikeyan RS; Satyanarayana V
    Int J Pharm; 2002 Jul; 241(2):353-66. PubMed ID: 12100863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
    Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
    AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic considerations in Roux-en-Y gastric bypass patients.
    Smith A; Henriksen B; Cohen A
    Am J Health Syst Pharm; 2011 Dec; 68(23):2241-7. PubMed ID: 22095812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
    Svane MS; Bojsen-Møller KN; Martinussen C; Dirksen C; Madsen JL; Reitelseder S; Holm L; Rehfeld JF; Kristiansen VB; van Hall G; Holst JJ; Madsbad S
    Gastroenterology; 2019 May; 156(6):1627-1641.e1. PubMed ID: 30742833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation.
    Tsume Y; Amidon GL
    Mol Pharm; 2010 Aug; 7(4):1235-43. PubMed ID: 20557130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Bioavailability of Single-Dose Extended-Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery.
    Krieger CA; Cunningham JL; Reid JM; Langman LJ; Grothe KB; Clark MM; Dierkhising RA
    Pharmacotherapy; 2017 Nov; 37(11):1374-1382. PubMed ID: 28845898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.